Congress Passes Bills Making Major Investments in Alzheimer’s Congress passes major investments in the fight against Alzheimer’s.

FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’s WASHINGTON, March 08, 2024 (GLOBE NEWSWIRE) -- The maker of donanemab, Eli Lilly, announced today that the Food and Drug Administration (FDA) will convene an advisory committee to consider the...